Status:
UNKNOWN
Tomosynthesis in the Oslo Breast Cancer Screening Program
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Norwegian Institute of Public Health
Hologic, Inc.
Conditions:
Recall Rate
Cancer Detection Rate
Eligibility:
FEMALE
50-69 years
Brief Summary
The Digital Breast Tomosynthesis (DBT) in the Oslo Mammography Screening Program will include women aged 50 to 69 years invited to the population-based mammography-screening program. All women attendi...
Eligibility Criteria
Inclusion
- Women 50 to 69 years who have signed the informed consent
Exclusion
- Women with pacemaker, implants, and severely disabled
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2015
Estimated Enrollment :
25000 Patients enrolled
Trial Details
Trial ID
NCT01248546
Start Date
November 1 2010
End Date
September 1 2015
Last Update
February 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital, Ulleval
Oslo, Oslo County, Norway, 0407